Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
CD4-expressing T cells in lymphoid organs are infected by the primary strains of HIV and represent one of the main sources of virus replication. Gene therapy strategies are being developed that allow the transfer of exogenous genes into CD4(+) T lymphocytes whose expression might prevent viral infection or replication. Insights into the mechanisms that govern virus entry into the target cells can be exploited for this purpose. Major determinants of the tropism of infection are the CD4 molecules on the surface of the target cells and the viral envelope glycoproteins at the viral surface. The best characterized and most widely used gene transfer vectors are derived from Moloney murine leukemia virus (MuLV). To generate MuLV-based retroviral gene transfer vector particles with specificity of infection for CD4-expressing cells, we attempted to produce viral pseudotypes, consisting of MuLV capsid particles and the surface (SU) and transmembrane (TM) envelope glycoproteins gp120-SU and gp41-TM of HIV type 1 (HIV-1). Full-length HIV-1 envelope glycoproteins were expressed in the MuLV env-negative packaging cell line TELCeB6. Formation of infectious pseudotype particles was not observed. However, using a truncated variant of the transmembrane protein, lacking sequences of the carboxyl-terminal cytoplasmic domain, pseudotyped retroviruses were generated. Removal of the carboxyl-terminal domain of the transmembrane envelope protein of HIV-1 was therefore absolutely required for the generation of the viral pseudotypes. The virus was shown to infect CD4-expressing cell lines, and infection was prevented by antisera specific for gp120-SU. This retroviral vector should prove useful for the study of HIV infection events mediated by HIV-1 envelope glycoproteins, and for the targeting of CD4(+) cells during gene therapy of AIDS.
Schnierle
B S
BS
Institut für Experimentelle Krebsforschung, Klinik für Tumorbiologie, Breisacher Strasse 117, D-79106 Freiburg, Germany.
Stitz
J
J
Bosch
V
V
Nocken
F
F
Merget-Millitzer
H
H
Engelstädter
M
M
Kurth
R
R
Groner
B
B
Cichutek
K
K
D015704:CD4 Antigens / Q000276:immunology*; D002460:Cell Line; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D015699:HIV Envelope Protein gp120 / Q000235:genetics*; D006801:Humans; D009052:Leukemia Virus, Murine / Q000235:genetics*; D016865:Reassortant Viruses / Q000235:genetics; D012192:Retroviridae Infections / Q000235:genetics / Q000276:immunology / Q000821:virology*; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology*; D014412:Tumor Virus Infections / Q000235:genetics / Q000276:immunology / Q000821:virology*
D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120